Send to

Choose Destination
Scand J Rheumatol. 1990;19(2):137-43.

Effect of MaxEPA in patients with SLE. A double-blind, crossover study.

Author information

Department of Nephrology, Sahlgrenska Sjukhuset, University of Göteborg, Sweden.


Seventeen patients with moderately active SLE participated in a double-blind, crossover study on the effect of MaxEPA, using olive oil as the control substance. During the first 3 months, 8/17 on Max EPA but only 2/17 on the control substance clinically and serologically improved (p = 0.05), but at 6 months there was no difference. The beneficial effect (if any) of MaxEPA on the disease was short-lived.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center